[PDF][PDF] ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

…, F Monville, J Dutcher, M Brown, J Jacquemier… - Cell stem cell, 2007 - cell.com
Application of stem cell biology to breast cancer research has been limited by the lack of
simple methods for identification and isolation of normal and malignant stem cells. Utilizing in …

[HTML][HTML] Breast cancer prognostic classification in the molecular era: the role of histological grade

…, V Eusebi, SB Fox, S Ichihara, J Jacquemier… - Breast cancer …, 2010 - Springer
Breast cancer is a heterogeneous disease with varied morphological appearances, molecular
features, behavior, and response to therapy. Current routine clinical management of …

[PDF][PDF] The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients …

SR Lakhani, MJ Van De Vijver, J Jacquemier… - Journal of clinical …, 2002 - core.ac.uk
… van de Vijver, Jocelyne Jacquemier, Thomas J. Anderson, Peter P. Osin, Lesley McGuffog,
and Douglas F. … Lakhani SR, Jacquemier J, Sloane JP, et al: Multifactorial analysis of …

Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients …

…, V Le Doussal, A Leroux, J Jacquemier… - Journal of clinical …, 1997 - ascopubs.org
PURPOSE Several histologic grading systems have been validated in soft tissue sarcomas (STS),
but no system is currently accepted worldwide. The National Cancer Institute (NCI) …

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

SR Lakhani, J Jacquemier, JP Sloane… - Journal of the …, 1998 - academic.oup.com
Background : We have previously demonstrated that breast cancers associated with
inherited BRCA1 and BRCA2 gene mutations differ from each other in their histopathologic …

[HTML][HTML] Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

…, T Decker, V Eusebi, SB Fox, S Ichihara, J Jacquemier… - Modern pathology, 2011 - Elsevier
Breast cancer is a heterogeneous disease encompassing a variety of entities with distinct
morphological features and clinical behaviors. Although morphology is often associated with …

Aldehyde dehydrogenase 1–Positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer

…, JM Extra, F Bertucci, J Jacquemier… - Clinical cancer …, 2010 - AACR
Purpose: To examine the role of cancer stem cells (CSC) in mediating metastasis in
inflammatory breast cancer (IBC) and the association of these cells with patient outcome in this …

Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype

…, P Radice, S Scherneck, H Sobol, J Jacquemier… - Clinical cancer …, 2005 - AACR
Purpose: To investigate the proportion of breast cancers arising in patients with germ line
BRCA1 and BRCA2 mutations expressing basal markers and developing predictive tests for …

Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group.

…, AM Mandard, MO Vilain, J Jacquemier… - Journal of Clinical …, 1996 - ascopubs.org
PURPOSE To define the prognostic factors in adult patients with locally controlled soft tissue
sarcoma (STS) and to determine which patients should be considered for adjuvant treatment…

Local recurrence after breast‐conserving surgery and radiotherapy. Frequency, time course, and prognosis

…, R Amalric, H Brandone, Y Ayme, J Jacquemier… - Cancer, 1989 - Wiley Online Library
Mammary recurrences were studied in 1593 patients with Stage I and II breast cancer
treated by macroscopically complete tumor excision followed by megavoltage radiotherapy, …